Development of a Glycoprotein D-Expressing Dominant-Negative and Replication-Defective Herpes Simplex Virus 2 (HSV-2) Recombinant Viral Vaccine against HSV-2 Infection in Mice

Using the T-REx (Invitrogen, California) gene switch technology and a dominant-negative mutant polypeptide of herpes simplex virus 1 (HSV-1)-origin binding protein UL9, we previously constructed a glycoprotein D-expressing replication-defective and dominant-negative HSV-1 recombinant viral vaccine,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Akhrameyeva, Natalie V., Zhang, Pengwei, Sugiyama, Nao, Behar, Samuel M., Yao, Feng
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2011
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3126160/
https://ncbi.nlm.nih.gov/pubmed/21389121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02548-10
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados